Story perspectives

China's Healthcare Sector Surges Amid Offshore Investments

4/11/2026

Summary

Story summary

Offshore capital drives gains in China's healthcare sector, with the Hang Seng Healthcare Index up 13% since March 23.
Investors remain cautious as analysts cite resilience to commodity price fluctuations amid global volatility, including Middle East tensions.
China's biotech subsector posted significant revenue growth in 2025.
Avita Medical shares rose 8.33% after a $25.5 million contract with the Biomedical Advanced Research and Development Authority (BARDA).

1 of 1

Story summary

Offshore capital drives gains in China's healthcare sector, with the Hang Seng Healthcare Index up 13% since March 23.
Investors remain cautious as analysts cite resilience to commodity price fluctuations amid global volatility, including Middle East tensions.
China's biotech subsector posted significant revenue growth in 2025.
Avita Medical shares rose 8.33% after a $25.5 million contract with the Biomedical Advanced Research and Development Authority (BARDA).